Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-26

Clinical Trial Update: Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating the Lopinavir/ritonavir tablet in HIV-infected children, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV-1 Infections | Phase 2 | Status: COMPLETED